SEC Info - Aclaris Therapeutics, Inc. - ‘ARS’ for 12/31/22

SEC Info℠

Home

Help

Please Sign In

Aclaris Therapeutics, Inc. – ‘ARS’ for 12/31/22

On: Thursday, 4/20/23, at 7:00am ET · Effective: 4/20/23 · For: 12/31/22 · Accession #: 1558370-23-6262 · File #: 1-37581

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/20/23  Aclaris Therapeutics, Inc.        ARS        12/31/22    1:3.7M                                   Toppan Merrill Bridge/FA

Annual Report to Security Holders

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: ARS         Annual Report to Security Holders --                 PDF   2.70M 
                acrs-20221231xars

This is a PDF Document.

	Download this Adobe® Acrobat® `.pdf` document

	Get Adobe® Acrobat® Reader™, if you haven’t done so already, in order to read this document.

↑Top

Filing Submission 0001558370-23-006262 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Aclaris Therapeutics, Inc. – ‘ARS’ for 12/31/22

On: Thursday, 4/20/23, at 7:00am ET · Effective: 4/20/23 · For: 12/31/22 · Accession #: 1558370-23-6262 · File #: 1-37581

Previous ‘ARS’: None · Next & Latest: ‘ARS’ on 4/25/24 for 12/31/23

Annual Report to Security HoldersFiling Table of Contents

This is a PDF Document.

Annual Report to Security Holders

Filing Table of Contents